Vitamin B3

About Vitamin B3

Available as nicotinic acid or nicotinamide (niacinamide); both support cellular energy and NAD+ synthesis, but only nicotinic acid improves lipid profiles by raising HDL cholesterol and lowering triglycerides — nicotinamide has zero effect on lipids. Nicotinic acid causes characteristic flushing (redness, warmth) at doses above 30–50 mg, while nicotinamide does not. Extended-release nicotinic acid (e.g. Slo-Niacin) reduces flushing but requires periodic liver function monitoring at therapeutic doses. Inositol hexanicotinate is marketed as flush-free but has less clinical evidence. Newer NAD+ precursors — nicotinamide riboside (NR, branded as Niagen/TruNiagen) and NMN — bypass the flushing pathway entirely and are increasingly used for cellular aging support, though long-term human evidence is still emerging.

What Vitamin B3 supports

• ⚡Drives energy metabolism
• 🧠Supports brain function
• ❤️Helps maintain healthy cholesterol

How much Vitamin B3 to take

Clinical studies typically use 25–500 mg of Vitamin B3. Common in B-complex and standalone formulations; UL 35 mg applies to flushing form only.

RDA

16 mg

Upper limit (UL)

35 mg

Effective range

25–500 mg

Forms of Vitamin B3 compared

• Nicotinic acid (flushing)Premium
  The lipid-active form — raises HDL and lowers triglycerides at 1–3 g/day, but causes flushing.
• NicotinamideStandard
  Non-flushing form for niacin deficiency and skin support; does NOT replicate niacin's lipid effects.
• NiacinamideStandard
  Non-flushing form for niacin deficiency and skin support; does NOT replicate niacin's lipid effects.
• Slow-release niacinBudget
  Sustained release reduces flush but carries hepatotoxicity risk above 1.5 g/day.
• Inositol hexanicotinate ("no-flush")Budget
  Marketed as "no-flush niacin" — poorly absorbed and doesn't replicate niacin's lipid effects.

Clinical evidence

Strong clinical evidence. Decades of clinical trials for cholesterol management; nicotinic acid form has the strongest data